Shine-On BioMedical Co (ROCO:6926) Total Stockholders Equity : NT$1,017.57 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co Total Stockholders Equity?

Shine-On BioMedical Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was NT$1,017.57 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shine-On BioMedical Co's Book Value per Share for the quarter that ended in Dec. 2024 was NT$20.48. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shine-On BioMedical Co's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.00.

Shine-On BioMedical Co Total Stockholders Equity Historical Data

The historical data trend for Shine-On BioMedical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co Total Stockholders Equity Chart

Shine-On BioMedical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

907.57

1,173.63

1,136.46

1,017.57

Shine-On BioMedical Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial					1,173.63	1,160.83	1,136.46	1,090.00	1,017.57

Shine-On BioMedical Co (ROCO:6926) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shine-On BioMedical Co's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1017.567	-	0)	/	49.692
	=	20.48

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shine-On BioMedical Co's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.241	+	1.356)	/	1017.567
	=	0.00

Shine-On BioMedical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shine-On BioMedical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shine-On BioMedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN

Website

https://www.shineon-bio.com

Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines